Meeder Asset Management Inc Artivion, Inc. Transaction History

Meeder Asset Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$13.31 - $23.25 $79 - $139	-6 Reduced 75.0%	2 $0
Q2 2022 Aug 08, 2022	SELL	$15.73 - $22.91 $519 - $756	-33 Reduced 80.49%	8 $0
Q1 2022 May 10, 2022	BUY	$16.95 - $21.74 $694 - $891	41 New	41 $1,000
Q1 2020 May 15, 2020	SELL	$14.66 - $30.57 $6,992 - $14,581	-477 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$22.45 - $27.09 $10,708 - $12,921	477 New	477 $13,000
Q2 2019 Aug 05, 2019	SELL	$27.55 - $32.39 $22,260 - $26,171	-808 Closed	0 $0
Q1 2019 Apr 16, 2019	BUY	$25.85 - $30.47 $20,886 - $24,619	808 New	808 $24,000
Q1 2018 May 03, 2018	SELL	$16.85 - $22.1 $3,033 - $3,978	-180 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$18.65 - $23.85 $3,356 - $4,293	180	180 $3,000

179

36.1M

33K

900

Ticker AORT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 40,316,100
Market Cap $1.25B
Description
Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.